DE602006014001D1 - Herstellung von 2-aminothiazol-5-carbonsäurederivaten - Google Patents

Herstellung von 2-aminothiazol-5-carbonsäurederivaten

Info

Publication number
DE602006014001D1
DE602006014001D1 DE602006014001T DE602006014001T DE602006014001D1 DE 602006014001 D1 DE602006014001 D1 DE 602006014001D1 DE 602006014001 T DE602006014001 T DE 602006014001T DE 602006014001 T DE602006014001 T DE 602006014001T DE 602006014001 D1 DE602006014001 D1 DE 602006014001D1
Authority
DE
Germany
Prior art keywords
aminothiazole
preparation
carboxylic acid
acid derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006014001T
Other languages
English (en)
Inventor
Frank Haunert
Norbert Goetz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE602006014001D1 publication Critical patent/DE602006014001D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602006014001T 2005-08-05 2006-08-03 Herstellung von 2-aminothiazol-5-carbonsäurederivaten Active DE602006014001D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05107247 2005-08-05
EP05107375 2005-08-11
PCT/US2006/030198 WO2007019210A1 (en) 2005-08-05 2006-08-03 Preparation of 2-amino-thiazole-5-carboxylic-acid derivatives

Publications (1)

Publication Number Publication Date
DE602006014001D1 true DE602006014001D1 (de) 2010-06-10

Family

ID=37487962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014001T Active DE602006014001D1 (de) 2005-08-05 2006-08-03 Herstellung von 2-aminothiazol-5-carbonsäurederivaten

Country Status (6)

Country Link
US (2) US7408069B2 (de)
EP (1) EP1919885B1 (de)
AT (1) ATE466003T1 (de)
DE (1) DE602006014001D1 (de)
ES (1) ES2342194T3 (de)
WO (1) WO2007019210A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE466003T1 (de) * 2005-08-05 2010-05-15 Bristol Myers Squibb Co Herstellung von 2-aminothiazol-5- carbonsäurederivaten
ES2565521T5 (es) * 2007-10-23 2019-12-10 Teva Pharma Polimorfos de dasatinib y proceso para la preparación de los mismos
US9365526B2 (en) 2012-12-31 2016-06-14 Sun Pharmaceutical Industries Limited Process for the preparation of dasatinib and its intermediates
CN104119292A (zh) * 2014-07-23 2014-10-29 天津市炜杰科技有限公司 一种达沙替尼中间体的制备方法
CN116808044A (zh) 2018-06-15 2023-09-29 汉达癌症医药责任有限公司 激酶抑制剂的盐类及其组合物
WO2020092650A1 (en) * 2018-10-30 2020-05-07 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating t cell exhaustion

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH1122773A4 (de) 1973-08-02 1975-02-14
JPS6339868A (ja) * 1986-08-04 1988-02-20 Otsuka Pharmaceut Factory Inc ジ低級アルキルフエノ−ル誘導体
WO2000062778A1 (en) * 1999-04-15 2000-10-26 Bristol-Myers Squibb Co. Cyclic protein tyrosine kinase inhibitors
JP2002338537A (ja) 2001-05-16 2002-11-27 Mitsubishi Pharma Corp アミド化合物およびその医薬用途
CN100357283C (zh) 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
BRPI0407283A (pt) 2003-02-13 2006-01-31 Banyu Pharma Co Ltd Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade
TWI338004B (en) * 2004-02-06 2011-03-01 Bristol Myers Squibb Co Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US20050215795A1 (en) * 2004-02-06 2005-09-29 Bang-Chi Chen Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7491725B2 (en) * 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
ATE466003T1 (de) * 2005-08-05 2010-05-15 Bristol Myers Squibb Co Herstellung von 2-aminothiazol-5- carbonsäurederivaten

Also Published As

Publication number Publication date
US7408069B2 (en) 2008-08-05
US20070037978A1 (en) 2007-02-15
ATE466003T1 (de) 2010-05-15
EP1919885B1 (de) 2010-04-28
US20090030203A1 (en) 2009-01-29
ES2342194T3 (es) 2010-07-02
US7932386B2 (en) 2011-04-26
WO2007019210A1 (en) 2007-02-15
EP1919885A1 (de) 2008-05-14

Similar Documents

Publication Publication Date Title
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
RS51341B (en) INTERMEDIATE COMPOUNDS FOR THE TRANS-5-CHLOR-2-METHYL-2,3A, 12B-TETRAHYDRO-1H-DIBENZE [2,3; 6,7] OXEPINO [4,5-C] Pyrrole
EA201000883A1 (ru) Производные индолинона и способ их получения
CY1113985T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
CY1112722T1 (el) Μυκητοκτονες συνθεσεις
HRP20120323T1 (en) Diarylhydantoin compounds
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
BR0305767A (pt) Métodos e composições para a preparação de derivados de ácido 4-substituìdo 3-hidroxibutìrico
CY1110034T1 (el) Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
GEP20135800B (en) Method of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives preparation
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
WO2009127718A3 (en) Novel microbiocides
TW200612959A (en) Method for preparing hydroxamic acids
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
DK1931636T3 (da) Isoquinoliner som IGF-1R-inhibitorer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition